Joint with: Immune Cell Therapies: Advances in Cancer and Autoimmune Disease
Cancer Immunotherapy: Clinical Lessons to New Modalities
Mar 16–19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Christian U Blank, Stefani Spranger and Anna Christina Obenauf
In Person
On Demand
Mar 16–19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Christian U Blank, Stefani Spranger and Anna Christina Obenauf
Available Formats:
In Person
On Demand
Supported by Chinese Society for Cell Biology, (Cell Research)
Available Formats: = In Person = On Demand
Merchandise Options
Registration Options
Sunday, March 16, 2025
Fundraising
Booking Function
Registration
4:00–8:00 PM
Van Horne Foyer
Welcome Mixer
6:00–8:00 PM
Van Horne Foyer
Monday, March 17, 2025
Breakfast
7:00–8:00 AM
Mezzanine 2
Welcome and Keynote Session (Joint)
8:00–9:30 AM
Van Horne Ballroom
Carl H. June, University of Pennsylvania
Cell Therapies: Current State of the Art
Cell Therapies: Current State of the Art
Ton N. Schumacher, Netherlands Cancer Institute
Dissecting T Cell Recognition of Cancer
Dissecting T Cell Recognition of Cancer
Coffee Break
9:30–9:50 AM
Van Horne Foyer
Overcoming Challenges in Immune and Cell Therapy: Insights into Mechanisms of Failure and Solutions (Joint)
9:50–12:00 PM
Van Horne Ballroom
Nathan Singh, Washington University School of Medicine
Genomic Regulation of CAR T Cell Driven Dysfunction
Genomic Regulation of CAR T Cell Driven Dysfunction
Shannon J Turley, Genentech, Inc.
CAF Targeting
CAF Targeting
Anna Christina Obenauf, Research Institute of Molecular Pathology
Rational Combination Therapies to Stimulate the APC Compartment
Rational Combination Therapies to Stimulate the APC Compartment
May Daher, MD Anderson Cancer Center
Metabolic Interventions to Enhance Adoptive Cellular Therapies
Metabolic Interventions to Enhance Adoptive Cellular Therapies
Poster Setup
12:00–1:00 PM
Mezzanine 2
On Own for Lunch
12:00–2:30 PM
Poster Viewing
1:00–10:00 PM
Mezzanine 2
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Van Horne A
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Van Horne Foyer
DC and Alternative Immune Cell Activation
5:00–7:00 PM
Van Horne A
Matthew F Krummel, University of California, San Francisco
Immune Archetypes
Immune Archetypes
Susan M Kaech, The Salk Institute
Metabolic Control of Anti-Tumor Immunity
Metabolic Control of Anti-Tumor Immunity
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai
DC Vaccination in Clinical Trials
DC Vaccination in Clinical Trials
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Mezzanine 2
Posters
7:30–10:00 PM
Mezzanine 2
Tuesday, March 18, 2025
Breakfast
7:00–8:00 AM
Mezzanine 2
Neoadjuvant Cancer Immunotherapy, Where are We Standing
8:00–11:00 AM
Van Horne A
Tina Cascone, University of Texas MD Anderson Cancer Center
Neoadjvant Cancer Immunotherapy in NSCLC
Neoadjvant Cancer Immunotherapy in NSCLC
Christian U Blank, Netherlands Cancer Institute - NKI-AVL
Personalized Neoadjuvant Cancer Immunotherapy in Melanoma
Personalized Neoadjuvant Cancer Immunotherapy in Melanoma
Peter Schmid †, Centre for Experimental Cancer Medicine, Barts Cancer Institute
Talk Title to be Announced
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Van Horne Foyer
Poster Setup
11:00–1:00 PM
Mezzanine 2
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Mezzanine 2
Career Roundtable (Joint)
3:00–4:30 PM
Van Horne B/C
Coffee Available
4:30–5:00 PM
Van Horne Foyer
Integrative Strategies in Cancer Immunotherapy: Harnessing Myeloid Cells, NK Cells, Unconventional T Cells and More
5:00–7:00 PM
Van Horne A
Stefani Spranger, Massachusetts Institute of Technology
DC Determine Quality of T Cell Responses
DC Determine Quality of T Cell Responses
Wolfgang Karl Kastenmueller, Universität Würzburg
Affinity Selection Phase during CD8 T Cell Priming
Affinity Selection Phase during CD8 T Cell Priming
Ann F. Cheung, Dragonfly Therapeutics
NK Cell Therapeutics
NK Cell Therapeutics
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Mezzanine 2
Posters
7:30–10:00 PM
Mezzanine 2
Wednesday, March 19, 2025
Breakfast
7:00–8:00 AM
Mezzanine 2
Cytokine/Chemokine Biology and Engineering
8:00–11:00 AM
Van Horne A
Jamie Spangler, Johns Hopkins University
Cytokine Engineering
Cytokine Engineering
Joanna R Groom, Walter and Eliza Hall Institute of Medical Research
Chemokine Signaling and Positioning in the LN
Chemokine Signaling and Positioning in the LN
Howard L. Kaufman, Massachusetts General Hospital and Ankyra Therapeutics
Anchored Cytokines for the Treatment of Cancer
Anchored Cytokines for the Treatment of Cancer
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Van Horne Foyer
On Own for Lunch
11:00–2:30 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Van Horne A
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Van Horne Foyer
Engineering in Cancer Immunotherapy to Enhance Efficacy (Joint)
5:00–6:30 PM
Van Horne Ballroom
Jaehyuk Choi, Northwestern University
Talk Title to be Announced
Talk Title to be Announced
Rosandra Natasha Kaplan, NCI, National Institutes of Health
Engineering of Myeloid Cells
Engineering of Myeloid Cells
Julia Carnevale, University of California, San Francisco
CRISPR-Based T Cell Editing to Enhance Cell Therapy
CRISPR-Based T Cell Editing to Enhance Cell Therapy
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) (Joint)
6:30–7:00 PM
Van Horne Ballroom
Social Hour with Lite Bites
7:00–8:00 PM
Mezzanine 2
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Thursday, March 20, 2025
Departure
12:00–11:59 PM
Subscribe for Updates